weight loss drug prescriptions semaglutide tirzepatide q3 2024 iqvia iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 Shortages improve for Lilly's GLP-1 weight loss drugs, bumping sales forecast by $3bn-bsmoothhr GLP-1 Antagonists Increase Plan Drug

Regulatory Status and Availability Retatrutide is currently in Phase 3 clinical trials

This precautionary approach exists because animal studies have shown potential risks to foetal development, although human pregnancy data remains limited

Because many GLP-1 therapies are prescribed to individuals with obesity or metabolic syndrome, separating medication effects from underlying risk factors can be difficult

Moreover, zinc oxide nanoparticles exhibit synergistic effects with a broad range of antibiotics, including chloramphenicol, amikacin, tetracycline, and ampicillin

A diet rich in fiber, probiotics, and prebiotics supports healthy digestion and metabolism